Skip to main content
Home
FDA
  • LOG IN
  • Thompson FDA
  • Manage Account
  •  
  • 1.800.677.3789

Main navigation

  • LIBRARY
    • FDA Enforcement Manual
    • Guide to Good Clinical Practice
    • FDA Advertising and Promotion Manual
    • Guide to Medical Device Regulation
    • Guide to U.S. Food Labeling Law
  • MY RESEARCH
  • NEWS
    • All News
    • FDA Intelligence
  • DATABASES
    • FDA Enforcement Database
    • Clinlaw State Database
  • RESOURCES
    • FDA Forms
    • Special Reports
    • Judicial Opinions
    • Interactive Tools
  • AGENCY GUIDANCE
    • Enforcement Guidance
    • Clinical Trials Guidance
    • Advertising and Promotion Guidance
    • Medical Device Guidance
    • Food Labeling Guidance
  • ASK THE EXPERT

Login to the Thompson
FDA Compliance Expert

Enter your FDA username.
Enter the password that accompanies your username.
Forgot password?

Questions? Give us a call! 1-800-677-3789

Advertising & Promotion

  • Aug 12, 2016
    Promotional Meeting Draws Ire of PMCPA and MHRA
  • Aug 10, 2016
    Biomet Says Additional Liabilities ‘Probable’ Due to Alleged Marketing Practices in Brazil, Mexico
  • Aug 10, 2016
    Dog Food Maker Settles with FTC Over False Ad Charges
  • Aug 5, 2016
    FDA National DTC Ad Survey Sent to OMB for Review
  • Aug 4, 2016
    N.Y. AG Tells Seven Companies Marketing Anti-Zika Products To Cease and Desist
  • Aug 3, 2016
    Less Formal Enforcement by FDA Reflects Changing Promotional Environment
  • Jul 30, 2016
    BIO and PhRMA Release Principles for Disseminating Truthful and Non-misleading Information
  • Jul 27, 2016
    Acclarent Resolves False Claims Charges Related to Alleged Off-label Marketing for $18 Million
  • Jul 21, 2016
    Two Former Acclarent Executives Convicted in Device Off-label Case; Company Pays $18 M.
  • Jul 20, 2016
    Medical Groups Support Senate Bill Exempting Educational Materials from Sunshine Act Reporting
  • More

Good Clinical Practice

  • Apr 8, 2017
    European Medicines Agency Releases Draft Guideline on Multiplicity Issues in Trials
  • Apr 8, 2017
    FDA Delays Mandatory Electronic Submission of Master Files By One Year
  • Apr 7, 2017
    Pa. Bill Clarifies Reimbursement from Inducement To Enter a Cancer Trial
  • Apr 7, 2017
    Pennsylvania Senate Bill Would Allow Minors Access to Investigational Products
  • Apr 6, 2017
    ASCO Supports Strengthening FDA Expanded Access; Opposes State and Federal ‘Right-to-Try’ Measures
  • Apr 3, 2017
    ACRP Starts Certified Professional Program
  • Apr 3, 2017
    UK Provides Guidance on Common Application Errors
  • Apr 3, 2017
    ASCO Issues Recommendations on Observational Research
  • Mar 28, 2017
    EMA Sets Up Technical Group To Develop Best Practices for Anonymizing Trial Data
  • Mar 24, 2017
    Brain Tumor Trial Finder Launched
  • More

FDA Regulation & Enforcement

  • Aug 22, 2019
    Guidance Posted on How to Measure, List Certain Items on Updated Labels
  • Aug 21, 2019
    OPDP Wants To Hear About Experiences With Third-Party eCTD Submissions
  • Aug 21, 2019
    Endo Settles with Two Ohio Counties
  • Aug 16, 2019
    CMS Proposes Changes to Open Payments Program
  • Aug 15, 2019
    Court: Arizona Statute Blocks Award of Punitive Damages Against Maker of Device with 510(k) Clearance
  • Aug 15, 2019
    FDA Threatens Enforcement Action Following Disclosure of AveXis Data Manipulation in Zolgensma BLA
  • Aug 14, 2019
    Study: Sesame Allergy More Widespread Than Previously Understood
  • Aug 14, 2019
    Six Companies Breached ABPI Code
  • Aug 9, 2019
    NZ Survey Finds Majority Would Ban DTC Ads If Independent Info Were Available
  • Aug 9, 2019
    Australian Court Fines Company $10 Million For Breaching Medicine Advertising Rules
  • More

Medical Devices

  • Jul 31, 2012
    Proposed Effective Dates of UDI Requirements
  • Jul 31, 2012
    New FDA Performance Goals Under MDUFA III
  • Jun 30, 2012
    OIG Recommends More Clarification, Training To Help Resolve Scientific Disagreements at CDRH
  • Jun 30, 2012
    CDRH Gears Up Mobile App for Voluntary Adverse Event Reporting; UDI Scanning Capability Planned
  • Jun 30, 2012
    Spectrum Dedicated to Medical Body Area Networks
  • Jun 30, 2012
    Device Company Owner Charged With Adulteration, Faces Three Years in Prison
  • May 31, 2012
    More Risk-based Approach to Device Trials Urged
  • May 31, 2012
    CDRH Scientists Concerned With Political, Business Influences, Postmarket Safety
  • May 31, 2012
    FDA Draft Guidance Targets Unnecessary Pediatric Radiation Exposure
  • Apr 30, 2012
    FDA's Draft Guidance on Substantial Equivalence Modifies Paradigm, Presents Additional Challenges
  • More

THOMPSON FDA

  • Thompson FDA
  • About Us
  • Manage Account
  • Our Parent Company

COMPLIANCE EXPERT

  • News
  • My Research
  • Our Experts
  •  

RESOURCES

  • FDA Forms
  • Special Reports

HELP

  • Customer Support
  •  
  •  
  •  
  •  

CONTACT

  • headquarter Headquarters
  • contact-number 1.800.677.3789
  • Contact Us
  •  

Copyright © Thompson FDA, a division of CBIS. All rights reserved.

  • Terms
  • Privacy

FDA NEWS
YOU CAN USE

Get instant, free access to the latest news and analysis to keep up with the shifting requirements, recommendations, and expectations of the FDA.

Something went wrong. Please try after some time.